RedHawk Holdings Corp (OTC: SNDD), a diversified holding company primarily engaged in sales and distribution of medical devices, has received an order to provide an expedited delivery for 2,000 of its digital non-contact thermometers to the City of New York, it was reported on Monday.
The company aims to complete delivery before the end of April.
Presently, the company offers for sale the SANDD mini and the SANDD Pro, an FDA approved digital non-contact thermometer, KN95 masks, and is to soon offer for sale a surgical mask.
DATROWAY receives US priority review for first-line metastatic triple negative breast cancer
Lupin launches Dasatinib tablets in US market
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Pharming receives FDA complete response letter for paediatric Joenja application
Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA
Frontage expands early phase clinical research capabilities across US and China
MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA
FDA approves Tenpoint Therapeutics' YUVEZZI as first dual-agent eye drop for presbyopia
Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA
WuXi Biologics collaborates with Sinorda Biomedicine for antibody development
Biogen's litifilimab receives FDA Breakthrough Therapy Designation for CLE
Glaukos receives FDA approval for repeat administration of iDose TR
Guerbet's contrast agent Elucirem approved by European Commission in children from birth
Spine Innovation's LOGIC Titanium Implant System receives US FDA 510(k) market approval